- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Potentially Undervalued Companies
Pakistani Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
1 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
Hoechst Pakistan
Market Cap: PK₨38.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,027.55
7D
0.7%
1Y
91.8%
GlaxoSmithKline Pakistan
Market Cap: PK₨143.1b
Operates as a biopharma company in Pakistan.
New
GLAXO
PK₨448.90
7D
-0.2%
1Y
129.5%